These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Neuroleptics. Development and current status]. Ginestet D Encephale; 1991 Jun; 17 Spec No 2():149-52. PubMed ID: 1677888 [No Abstract] [Full Text] [Related]
25. [Drug treatments, from chlorpromazine to new molecules]. Gaillard A; Poirier MF Soins Psychiatr; 2013; (286):25-9. PubMed ID: 23757890 [TBL] [Abstract][Full Text] [Related]
26. Antipsychotics--history of development and field of indication, new wine--old glassess. Jašović-Gašić M; Vuković O; Pantović M; Cvetić T; Marić-Bojović N Psychiatr Danub; 2012 Oct; 24 Suppl 3():S342-4. PubMed ID: 23114814 [TBL] [Abstract][Full Text] [Related]
27. The evolution of drug development in schizophrenia: past issues and future opportunities. Carpenter WT; Koenig JI Neuropsychopharmacology; 2008 Aug; 33(9):2061-79. PubMed ID: 18046305 [TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric disorders: The choice of antipsychotics in schizophrenia. Margolis RL Nat Rev Neurol; 2009 Jun; 5(6):308-10. PubMed ID: 19498434 [TBL] [Abstract][Full Text] [Related]
29. [Application of pharmacotherapy with classic neuroleptics: phenothiazine derivatives in schizophrenia]. Kleszczewska E; Hejza J Pol Merkur Lekarski; 2003 Feb; 14(80):136-8. PubMed ID: 12728674 [TBL] [Abstract][Full Text] [Related]
30. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other. Fleischhacker WW; Widschwendter CG Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191 [TBL] [Abstract][Full Text] [Related]
31. [Neuroleptics or antipsychotic agents]. Dresse A Rev Med Liege; 1996 Jan; 51(1):65-9. PubMed ID: 8701140 [No Abstract] [Full Text] [Related]
32. What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Karow A; Schnedler D; Naber D Pharmacopsychiatry; 2006 Mar; 39(2):47-51. PubMed ID: 16555164 [TBL] [Abstract][Full Text] [Related]
33. [Biological treatments of schizophrenia]. Dollfus S; Petit M Rev Prat; 1991 Mar; 41(7):615-9. PubMed ID: 1674170 [TBL] [Abstract][Full Text] [Related]
34. [Clinical classification of neuroleptics. Critical study and current prospects]. Kapsambelis V; Gekiere C; Ginestet D Encephale; 1990; 16(2):63-70. PubMed ID: 1972056 [TBL] [Abstract][Full Text] [Related]
35. Neurosyphilis, malaria, and the discovery of antipsychotic agents. Frankenburg FR; Baldessarini RJ Harv Rev Psychiatry; 2008; 16(5):299-307. PubMed ID: 18803105 [TBL] [Abstract][Full Text] [Related]
37. [The quest for the pharmacological treatment of schizophrenia: from conventional neuroleptics to atypical antipsychotics and beyond]. Dratcu L Vertex; 2010; 21(93):385-93. PubMed ID: 21218203 [TBL] [Abstract][Full Text] [Related]
39. [Current questions on the use of neuroleptics in everyday practice]. Perényi A; Frecska E Orv Hetil; 1984 Dec; 125(49):2985-8, 2991. PubMed ID: 6151164 [No Abstract] [Full Text] [Related]